Pulmonary Hypertension Biorepository and Registry
-
- STATUS
- Recruiting
-
- End date
- Jul 31, 2026
-
- participants needed
- 300
-
- sponsor
- University of Kansas Medical Center
Summary
Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.
Description
The aim of this project will be to establish a broad and wide-ranging registry and biorepository of blood samples from patients with pulmonary hypertension, including all WHO groups I-V to be used for future research in these areas. This will be both a retrospective and prospective project. The registry and biorepository will be utilized to study and grow our knowledge of the cellular mechanisms and mediators of the disease and, in turn, contribute to advancements in treatment.
Details
| Condition | Surviving Abuse, Indikation: Diabetes - Typ II, Joint Injuries, Cancer Treatment, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension Due to Left Heart Disease, Myopic Macular Degeneration, idiopathic pulmonary hypertension, Stasis Dermatitis, Catheter Complications, Mental Disability, Severe Premenstrual Symptom, Infantile Fibrosarcoma, Complicated Grief, Memory Problems, Pulmonary Hypertension, Primary, 3, CTEPH, Pseudobulbar Affect, Late Infantile Neuronal Ceroid Lipfuscinsosis, Pulmonary Arterial Hypertension, Anemic Cancer, Cancer Prevention, Chronic Pelvic Pain, Renal Anemia, Testotoxikose, thromboembolic pulmonary hypertension, Low Testosterone, Functional Dyspepsia, Gambling Problems, Abdominal Surgery, Primary Pulmonary Hypertension, Nerve Injury, Partial Medial Meniscectomy, Spinocerebellar Disorders, Primary Insulin Hypersecretion, Chronic Renal Anemia, Open Heart Surgery, Recurrent Pregnancy Loss, Pelvic Adhesions, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension, Primary, 4, Spine Athroplasty, Habit Reversal, Effects of Chemotherapy, Dental Filling, Pulmonary Hypertension, Serial Evaluation of Ductal Epithelium, Pulmonary Hypertension, Primary, 2 |
|---|---|
| Clinical Study Identifier | NCT04808596 |
| Sponsor | University of Kansas Medical Center |
| Last Modified on | 10 June 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer